Cargando…

Insulin Resistance and Type 2 Diabetes

Detalles Bibliográficos
Autor principal:	Taylor, Roy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2012
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314346/ https://www.ncbi.nlm.nih.gov/pubmed/22442298 http://dx.doi.org/10.2337/db12-0073

Ejemplares similares

Inflammation, Insulin Resistance, and Type 2 Diabetes: Back to the Future?
por: Cefalu, William T.
Publicado: (2009)

The Intriguing Intersection of Type 2 Diabetes, Obesity-Related Insulin Resistance, and Osteoarthritis
por: Bradley, David
Publicado: (2021)

Topics in Type 2 Diabetes and Insulin Resistance
por: Bloomgarden, Zachary T.
Publicado: (2009)

The Value of Insulin Degludec in Frail Older Adults with Type 2 Diabetes
por: Strain, W. David, et al.
Publicado: (2021)

Cardiovascular safety of long‐acting insulin analogs in type 2 diabetes patients: Is there a better basal insulin?
por: Chang, Chia‐Hsuin, et al.
Publicado: (2017)

Loss of Pulsatile Insulin Secretion: A Factor in the Pathogenesis of Type 2 Diabetes?
por: Wahren, John, et al.
Publicado: (2012)

Selecting Insulin Regimens for the Management of Non-ICU Patients With Type 2 Diabetes
por: Migdal, Alexandra L, et al.
Publicado: (2021)

Exercise in type 2 diabetes: to resist or to endure?
por: Roden, M.
Publicado: (2012)

One Hundred Years of Insulin: Value Beyond Price in Type 2 Diabetes Mellitus
por: Evans, Marc, et al.
Publicado: (2021)

Delineating the transcriptional atlas for impaired insulin secretion: A window into type 2 diabetes pathophysiology
por: Li, Jian, et al.
Publicado: (2023)

Is Endogenous GLP-1 the Only Important Enhancer of Glucose-Induced Insulin Secretion in Type 2 Diabetes?
por: Deacon, Carolyn F.
Publicado: (2012)

GLUT12: a second insulin‐responsive glucose transporters as an emerging target for type 2 diabetes
por: Matsuzaka, Takashi, et al.
Publicado: (2011)

Metformin induces insulin secretion by preserving pancreatic aquaporin 7 expression in type 2 diabetes mellitus
por: Kimura, Tomohiko, et al.
Publicado: (2021)

Commentary to “Differential Effect of Hypoalbuminemia on Hypoglycemia on Type 2 Diabetes Patients Treated with Insulin Glargine 300 U/ml and Insulin Degludec” by Kawaguchi et al. Diabetes Therapy 2019
por: Pieber, Thomas R., et al.
Publicado: (2020)

Targeting CITED2 for Angiogenesis in Obesity and Insulin Resistance
por: Jia, Guanghong, et al.
Publicado: (2016)

Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes
por: Kalra, Sanjay
Publicado: (2017)

Microvascular Contributions to Insulin Resistance
por: Rattigan, Stephen, et al.
Publicado: (2013)

Combination therapy in type 2 diabetes mellitus: adding empagliflozin to basal insulin
por: Ahmann, Andrew
Publicado: (2015)

Basal insulin delivery reduction for exercise in type 1 diabetes: finding the sweet spot
por: Thabit, Hood, et al.
Publicado: (2016)

O-GlcNAc and aging: C. elegans as a genetic model to test O-GlcNAc roles in type II diabetic insulin resistance
por: Vosseller, Keith
Publicado: (2010)

Results of Insulin Therapy in Type 2 Diabetes Mellitus Patients in the Czech Republic: Do They Reflect the Current Status in Other Countries?
por: Brož, Jan, et al.
Publicado: (2019)

Obesity and Insulin Resistance: An Ongoing Saga
por: Kim, Sun H., et al.
Publicado: (2010)

Surplus Ceramides: An Added Twist in the Tale of TREM2 and Insulin Resistance
por: Webster, Kierstin L., et al.
Publicado: (2021)

Does Inhibition of β-Cell Proliferation by Free Fatty Acid in Mice Explain the Progressive Failure of Insulin Secretion in Type 2 Diabetes?
por: Boden, Guenther
Publicado: (2012)

Centenary of the discovery of insulin: People with diabetes in Africa still have poor access to insulin
por: Mbanya, Jean Claude, et al.
Publicado: (2021)

Role of cardiotrophin-1 in obesity and insulin resistance
por: Moreno-Aliaga, María J., et al.
Publicado: (2012)

Nicotine and Insulin Resistance: When the Smoke Clears
por: Bajaj, Mandeep
Publicado: (2012)

Targeting Ceramide Synthesis to Reverse Insulin Resistance
por: Schmitz-Peiffer, Carsten
Publicado: (2010)

Linking maternal obesity to early insulin resistance()
por: Ussar, Siegfried
Publicado: (2014)

Do mitochondria care about insulin resistance?
por: Koliaki, Chrysi, et al.
Publicado: (2014)

Changing the Way We Think About Endothelial Cell Insulin Sensitivity, Nitric Oxide, and the Pathophysiology of Type 2 Diabetes: The FoxO Is Loose
por: Kearney, Mark T.
Publicado: (2013)

Modern insulins, old paradigms and pragmatism: choosing wisely when deciding how to treat type 1 diabetes
por: Schaan, Beatriz D, et al.
Publicado: (2015)

Ceramide and Insulin Resistance: How Should the Issue Be Approached?
por: Górski, Jan
Publicado: (2012)

The Vascular Contribution to Insulin Resistance: Promise, Proof, and Pitfalls
por: Barrett, Eugene J., et al.
Publicado: (2012)

Aging and Insulin Resistance: Just Say iNOS
por: Evans, Joseph L., et al.
Publicado: (2013)

Insulin Resistance by Adiponectin Deficiency: Is the Action in Skeletal Muscle?
por: Karpe, Fredrik
Publicado: (2013)

Unraveling the Mechanisms Underlying Olanzapine-Induced Insulin Resistance
por: Irwin, Nigel, et al.
Publicado: (2013)

Mediators of insulin resistance & cardiometabolic risk: Newer insights
por: Bodhini, Dhanasekaran, et al.
Publicado: (2018)

Does Insulin Resistance Trigger Natriuretic Peptide Deficiency?
por: Moro, Cedric
Publicado: (2017)

Insulin resistance and type 2 diabetes in children
por: Castorani, Valeria, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_19mqh6fv69b1t6jd430fm4mogn